Sensorcaine Mpf Injection, Solution
Product Images NDC 0404-9946
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sensorcaine Mpf (NDC 0404-9946). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Formula2.jpg (Formula2)
Image1.jpg (Image1)
The use of 0.75% Sensorcaine concentration during obstetrical anesthesia is not recommended due to reports of cardiac arrest, difficult resuscitation, and death. Local anesthetics should only be used by experts in management of dose-related toxicity and other acute emergencies. Local anesthesia solutions with antimicrobial preservatives should not be used for epidural or caudal anesthesia. Post-marketing reports have shown cases of chondrolysis following intra-articular infusions of local anesthetics. Aspiration for blood or cerebrospinal fluid is recommended before injecting local anesthetics. Bupivacaine with Epinephrine 1:200,000 should not be used with ergot-type oxytocic drugs. Bupivacaine administration is not recommended for children younger than 12 years. Bupivacaine should not be mixed or used with any other local anesthetic. Bupivacaine use during intravenous regional anesthesia (Bier Block) has led to reports of cardiac arrest and death.*
Image2.jpg (Image2)
This text is a list of drugs that are associated with causing Methemoglobinemia, which is a condition where the blood is unable to carry oxygen effectively. The different classes of drugs include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and other drugs such as acetaminophen, metoclopramide, quinine, and sulfasalazine.*
Label1.jpg (Label1)
This is a medication called SENSORCAIME MPF 0.6%, also known as Bupivacaine HCL, used for nerve blocking, caudal and epidural anesthesia. It should not be used for spinal anesthesia, and the unused portion should be discarded. Each milliliter of solution contains 5mg of Bupivacaine HCL and is adjusted to pH 4.0-6.5 using sodium chloride, sodium hydroxide, and/or hydrochloric acid. The medication comes in a 10ml single-dose vial and should not be used if the solution is discolored or contains a precipitate. It can be resterilized by autoclaving. The medication is methylparaben-free and should be kept out of children's reach at a controlled room temperature of 68-73°F. The packaging information including GTIN, SER, LOT, and EXP dates is also provided.*
Table1.jpg (Table1)
This text provides information about different types of local anesthesia and blocks, with varying percentages based on the type of procedure. It includes details on infiltration, nerve blocks, retrobulbar block, sympathetic block, lumbar epidural, caudal, epidural test dose, and dental blocks. The dosage and administration information is also mentioned.*
Table2.jpg (Table2)
Table3.jpg (Table3)
Table4.jpg (Table4)
This is a list of medication products with their strengths, quantities, and packaging information. The products seem to be single-dose vials and trays with either 5mg per 10ml or 75mg per 30ml strengths, and pack counts of 25 and 30. The products are labeled as being without epinephrine, and some have a strength of 0.25%, while others have a strength of 0.5%.*
Table5.jpg (Table5)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.